#United States #New York #NYU Langone #Perlmutter Cancer Center #Ishwaria Subbiah

Dr. Ishwaria Subbiah Takes Leadership Role at Perlmutter Cancer Center

In a significant development for cancer care, NYU Langone Health has announced the appointment of Dr. Ishwaria Subbiah as the director of the Symptom Management Program for hematology and medical oncology at the Perlmutter Cancer Center. Effective November 1, 2026, Dr. Subbiah brings her expertise in supportive and palliative care, with a focused mission to enhance the quality of life for patients navigating the complexities of cancer treatment.

Dr. Subbiah has established herself as a leading figure in symptom management through her evidence-based approaches, which include medication, behavioral interventions, and lifestyle adjustments to alleviate the discomforts associated with cancer therapies. Dr. Anirban Maitra, director of the Perlmutter Cancer Center, hailed her extensive experience, particularly in clinical trials and symptom alleviation, which aligns with the center's goal of translating scientific advancements into patient-centric care.

With an increasing number of people living with cancer, Dr. Subbiah's role is more critical than ever. She will lead research initiatives focused on innovative strategies to reduce the burdens of side effects such as pain, fatigue, and nausea, thereby allowing patients to engage fully in their lives while undergoing treatment. In her own words, Dr. Subbiah expressed admiration for NYU Langone's commitment to impactful action, stating, "The institution’s blend of purpose and innovation uniquely positions us to provide cutting-edge treatments coupled with holistic support for exemplary patient care."

Dr. Subbiah's wealth of experience spans over 16 years in direct patient management, further enhanced by significant leadership roles in developing comprehensive programs for managing treatment-related toxicities. Before joining NYU Langone, she served as an associate professor at MD Anderson Cancer Center, where she not only provided expert care but also spearheaded research projects aimed at improving clinical trial accessibility for older patients and reducing the psychosocial burdens of cancer treatment.

Notable among her accomplishments is her leadership in launching a remote symptom monitoring program integrated within electronic health records, successfully managing over 50,000 patient interactions each month. Her move toward community oncology has allowed her to operationalize evidence-based practices that cater to real-world patient needs, demonstrating her commitment to accessible care.

Dr. John P. Leonard, chief of the Division of Hematology and Medical Oncology at NYU Grossman School of Medicine, emphasized the personalized nature of symptom management, noting, "Dr. Subbiah will enhance our ability to provide empathetic and respectful care, treating the patient as a whole rather than merely addressing their illness."

Dr. Subbiah's leadership in the health field is underscored by her chair role at the Health Services Research Committee for the American Society of Clinical Oncology (ASCO) and her contributions to various advisory groups focusing on supportive care guidelines. She has effectively secured multi-year funding from reputable organizations to support her research initiatives and has been fundamental in leading multiple clinical trials that bridge technology with patient care.

As she embarks on this pivotal journey at Perlmutter Cancer Center, the integration of her innovative perspectives and compassionate approach to cancer care prepares NYU Langone Health to continue its track record of excellence in patient outcomes, further establishing the center as a leader in comprehensive cancer care services.

In summary, with Dr. Ishwaria Subbiah at the helm of the Symptom Management Program, NYU Langone Health is poised to make significant strides in enhancing the quality of life for cancer patients while advancing a holistic approach to treatment that values the person as much as the disease.

About NYU Langone Health

NYU Langone Health is recognized for its unwavering commitment to quality and patient outcomes, consistently ranked as a top institution for comprehensive medical care across a wide array of specialties. Its integrated health system includes advanced medical services and education, further emphasizing its dedication to leading innovations in health care.